CA2962916A1 - Capsules molles enteriques a liberation controlee d'esters de fumarate - Google Patents

Capsules molles enteriques a liberation controlee d'esters de fumarate Download PDF

Info

Publication number
CA2962916A1
CA2962916A1 CA2962916A CA2962916A CA2962916A1 CA 2962916 A1 CA2962916 A1 CA 2962916A1 CA 2962916 A CA2962916 A CA 2962916A CA 2962916 A CA2962916 A CA 2962916A CA 2962916 A1 CA2962916 A1 CA 2962916A1
Authority
CA
Canada
Prior art keywords
fae
composition
weight
fumarate
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2962916A
Other languages
English (en)
Other versions
CA2962916C (fr
Inventor
Tatyana Dyakonov
Sunil AGNIHOTRI
Aqeel A. Fatmi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Banner Life Sciences LLC
Original Assignee
Banner Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2015/017893 external-priority patent/WO2015130998A1/fr
Application filed by Banner Life Sciences LLC filed Critical Banner Life Sciences LLC
Publication of CA2962916A1 publication Critical patent/CA2962916A1/fr
Application granted granted Critical
Publication of CA2962916C publication Critical patent/CA2962916C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
CA2962916A 2014-10-08 2015-08-31 Capsules molles enteriques a liberation controlee d'esters de fumarate Expired - Fee Related CA2962916C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462061185P 2014-10-08 2014-10-08
US62/061,185 2014-10-08
US14/633,164 2015-02-27
PCT/US2015/017893 WO2015130998A1 (fr) 2014-02-28 2015-02-27 Capsules molles entériques à libération contrôlée d'esters de fumarate
USPCT/US15/17893 2015-02-27
US14/633,164 US9326965B2 (en) 2014-02-28 2015-02-27 Controlled release fumarate esters
PCT/US2015/047636 WO2016057133A1 (fr) 2014-10-08 2015-08-31 Capsules molles entériques à libération contrôlée d'esters de fumarate

Publications (2)

Publication Number Publication Date
CA2962916A1 true CA2962916A1 (fr) 2016-04-14
CA2962916C CA2962916C (fr) 2021-06-15

Family

ID=55653524

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2962916A Expired - Fee Related CA2962916C (fr) 2014-10-08 2015-08-31 Capsules molles enteriques a liberation controlee d'esters de fumarate

Country Status (4)

Country Link
AU (2) AU2015328676B2 (fr)
CA (1) CA2962916C (fr)
IL (1) IL251402A0 (fr)
WO (1) WO2016057133A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE14172396T1 (de) 2004-10-08 2015-01-08 Forward Pharma A/S Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
EP3766487A1 (fr) 2014-02-28 2021-01-20 Banner Life Sciences LLC Capsules entériques molles à libération contrôlée d'esters de fumarate
MA39743A (fr) 2014-03-14 2017-01-18 Biogen Ma Inc Fumarate de diméthyle et régimes de vaccination
MA40985A (fr) 2014-11-17 2017-09-26 Biogen Ma Inc Méthodes de traitement de la sclérose en plaques
WO2021021520A1 (fr) * 2019-07-26 2021-02-04 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Activation de nrf2 pour le traitement du diabète insipide néphrogénique
WO2021142062A1 (fr) 2020-01-10 2021-07-15 Banner Life Sciences Llc Formes posologiques d'ester de fumarate présentant une tolérabilité gastro-intestinale améliorée

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721099C2 (de) * 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
JP5248739B2 (ja) * 2002-10-01 2013-07-31 バナー ファーマキャップス， インコーポレーテッド 腸溶性調製物
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス，インコーポレイティド 制御放出製剤
DE14172396T1 (de) * 2004-10-08 2015-01-08 Forward Pharma A/S Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester
EP1951206A1 (fr) * 2005-10-07 2008-08-06 Aditech Pharma AB Compositions pharmaceutiques a liberation controlee comportant un ester de l'acide fumarique
KR20090028047A (ko) * 2007-09-13 2009-03-18 경북대학교 산학협력단 디메틸푸마레이트의 신규 용도
CN114146081A (zh) * 2012-02-07 2022-03-08 比奥根玛公司 含有富马酸二甲酯的药物组合物
EP3766487A1 (fr) * 2014-02-28 2021-01-20 Banner Life Sciences LLC Capsules entériques molles à libération contrôlée d'esters de fumarate

Also Published As

Publication number Publication date
AU2017204505B2 (en) 2018-08-02
AU2015328676B2 (en) 2017-07-20
AU2015328676A1 (en) 2017-04-20
CA2962916C (fr) 2021-06-15
AU2017204505A1 (en) 2017-07-20
IL251402A0 (en) 2017-05-29
WO2016057133A1 (fr) 2016-04-14

Similar Documents

Publication Publication Date Title
US10918616B2 (en) Fumarate ester pharmaceutical compositions
US10918617B2 (en) Fumarate ester pharmaceutical compositions
US11590095B2 (en) Fumarate ester dosage forms
CA2962916C (fr) Capsules molles enteriques a liberation controlee d'esters de fumarate
US10918615B2 (en) Fumarate esters
WO2017040272A1 (fr) Formes posologiques d'ester de fumarate
WO2017151184A1 (fr) Formes posologiques d'ester de fumarate

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180727

MKLA Lapsed

Effective date: 20210831